This page has not been authorized, sponsored, or otherwise approved or endorsed by the companies represented herein. Each of the company logos represented herein are trademarks of Microsoft Corporation; Dow Jones & Company; Nasdaq, Inc.; Forbes Media, LLC; Investor's Business Daily, Inc.; and Morningstar, Inc.
Copyright 2024 Zacks Investment Research | 10 S Riverside Plaza Suite #1600 | Chicago, IL 60606
At the center of everything we do is a strong commitment to independent research and sharing its profitable discoveries with investors. This dedication to giving investors a trading advantage led to the creation of our proven Zacks Rank stock-rating system. Since 1988 it has more than doubled the S&P 500 with an average gain of +24.15% per year. These returns cover a period from January 1, 1988 through June 3, 2024. Zacks Rank stock-rating system returns are computed monthly based on the beginning of the month and end of the month Zacks Rank stock prices plus any dividends received during that particular month. A simple, equally-weighted average return of all Zacks Rank stocks is calculated to determine the monthly return. The monthly returns are then compounded to arrive at the annual return. Only Zacks Rank stocks included in Zacks hypothetical portfolios at the beginning of each month are included in the return calculations. Zacks Ranks stocks can, and often do, change throughout the month. Certain Zacks Rank stocks for which no month-end price was available, pricing information was not collected, or for certain other reasons have been excluded from these return calculations. Zacks may license the Zacks Mutual Fund rating provided herein to third parties, including but not limited to the issuer.
Visit Performance Disclosure for information about the performance numbers displayed above.
Visit www.zacksdata.com to get our data and content for your mobile app or website.
Real time prices by BATS. Delayed quotes by Sungard.
NYSE and AMEX data is at least 20 minutes delayed. NASDAQ data is at least 15 minutes delayed.
This site is protected by reCAPTCHA and the Google Privacy Policy, DMCA Policy and Terms of Service apply.
View All Zacks #1 Ranked Stocks
Zacks News
Factors Likely to Influence Molson Coors' (TAP) Q3 Earnings
by Zacks Equity Research
Molson Coors (TAP) has a dismal top and bottom line trend. Also, it continues to battle input cost inflation. However, its restructuring plans to reduce costs and boost profitability are impressive.
Molson Coors Brewing (TAP) Q3 Earnings Preview: How Are Events Shaping Up?
by Zacks Equity Research
Molson Coors (TAP) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Walmart's Canada Unit Eyes Prospects in Cannabis Products
by Zacks Equity Research
Walmart (WMT) explores opportunities to sell cannabis-infused products in Canada.
Bear of the Day: Constellation Brands (STZ)
by Benjamin Rains
This alcoholic beverage giant is embarking on a new journey and its earnings revisions are trending in the wrong direction.
Molson Coors and HEXO Joint Venture Goes Live as "Truss"
by Zacks Equity Research
Molson Coors Canada (TAP) and Hydropothecary launch its JV, Truss, to explore the non-alcoholic cannabis-infused drinks market, just before cannabis trade is legalized in Canada.
After Coke, It's PepsiCo's Turn to Monitor Cannabis Market
by Zacks Equity Research
The cannabis-infused beverages industry is growing fast, attracting the attention of food and beverage giants.
TAP vs. DVDCY: Which Stock Is the Better Value Option?
by Zacks Equity Research
TAP vs. DVDCY: Which Stock Is the Better Value Option?
Can Molson Coors Survive on Strategies as Beer Loses Fizz?
by Zacks Equity Research
Molson Coors (TAP) looks attractive, based on its focus on cost savings and premiumization as well as exposure to the marijuana space. But, overall softness in the beer industry weighs on the stock.
Top Wall Street Stories of the Third Quarter
by Sweta Killa
We discuss some of the events that dominated the headlines in the third quarter and influenced the market.
SAM Vs. TAP: Which Stock is Better Placed as Beer Loses Fizz?
by Zacks Equity Research
Beer space suffers due to soft beer sales, thanks to consumers shift to healthier options. However, players with diversified portfolio stand to gain. Let's see which a better stock in this space is.
Know How Beverage Stocks Will Gain From Shift to Marijuana
by Rajani Lohia
Cannabis-infused drinks have emerged as an attractive alternative to the problems of the players in the U.S. beverage space, given the health benefits it offers.
Coke Eyes Cannabis-Infused Beverages, Will Others Follow?
by Zacks Equity Research
Infused-drinks could emerge as the next big thing in the beverage market, attracting the focus of many big players.
Is Coca-Cola's Cannabis Venture a Solution to Its Problems?
by Zacks Equity Research
Coca-Cola (KO) explores the cannabis-infused drinks market to combat the fading popularity of sugary carbonated sodas.
Molson Coors (TAP) Down 2.8% Since Last Earnings Report: Can It Rebound?
by Zacks Equity Research
Molson Coors (TAP) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.
5 Best Stocks of the Top ETF of August
by Sweta Killa
Cannabis-related ETFMG Alternative Harvest ETF (MJ) is the best-performing ETF of August, gaining 22.5% and attracting $22 million in AUM.
What Investors Need to Know About Investing In Marijuana Stocks
by Benjamin Rains
Marijuana has come a long way since California legalized cannabis for medicinal use back in 1996. Today, the industry and marijuana look to be on the cusp of unprecedented acceptance, with major international giants investing billions into publicly traded cannabis companies. So let's take a look at what investors need to know about the marijuana industry and how to invest in the future of pot.
Constellation Brands Invests in Cannabis, Expands Canopy Stake
by Zacks Equity Research
Constellation Brands (STZ) expands its stake in Canada's Canopy Growth Corporation to 38% through an additional $5-billion investment.
CRON, CGC Sink Ahead of Earnings: What To Watch From These Pot Stocks
by Benjamin Rains
Recreational marijuana is now legal in Canada as well as a number of states in the U.S. Companies have raced to get in on the multibillion-dollar a year industry, so let's see how two of the bigger pure-play pot stocks, Cronos Group (CRON) and Canopy Growth (CGC), are projected to perform Tuesday.
Micron, Ultra Clean Holdings, Scotts Miracle-Gro, GW Pharmaceuticals, Innovative Industrial Properties, Molson Coors and Constellation Brands highlighted as Zacks Bull and Bear of the Day
by Zacks Equity Research
Micron, Ultra Clean Holdings, Scotts Miracle-Gro, GW Pharmaceuticals, Innovative Industrial Properties, Molson Coors and Constellation Brands highlighted as Zacks Bull and Bear of the Day
Where to Find the Best Marijuana Stocks
by Tracey Ryniec
The marijuana industry continues to grow and so do the investing opportunities. Where can you find them now?
Where to Find the Best Marijuana Stocks
by Tracey Ryniec
The marijuana industry continues to grow and so do the investing opportunities. Where can you find them now?
Can Beer & Soda Makers Survive Trump Tariffs With Price Hike?
by Ritujay Ghosh
Higher tariffs on aluminum have started pinching the profits of beer and soft beverage manufacturers. Understandably, the higher prices are now being passed on to consumers.
Molson Coors (TAP) Stock Declines Despite Q2 Earnings Beat
by Zacks Equity Research
Molson Coors (TAP) beats earnings and sales estimates for second-quarter 2018 due to favorable global net pricing, realized cost savings, lower marketing spend and a lower tax rate.
Molson Coors (TAP) Beats on Q2 Earnings & Revenue Estimates
by Zacks Equity Research
Molson Coors (TAP) came out with second-quarter 2018 results, wherein adjusted earnings of $1.88 per share outpaced the Zacks Consensus Estimate of $1.84.
Will Restructuring Drive Molson Coors' (TAP) Q2 Earnings?
by Zacks Equity Research
Molson Coors' (TAP) restructuring initiatives along with other strategic measures are likely to reduce costs and boost profitability in the second quarter.